Xeris Pharmaceuticals, Inc. · 6 days ago
Clinical Project Manager
Xeris Pharmaceuticals, Inc. is focused on innovative therapies, and they are seeking a Clinical Project Manager to oversee the operational aspects of clinical trials. The role involves managing clinical studies, ensuring compliance with regulatory requirements, and collaborating with internal and external stakeholders for successful trial outcomes.
BiotechnologyDiabetesHealth CarePharmaceuticalTherapeutics
Responsibilities
Manage and lead the day-to-day operations of assigned studies to ensure completion per established project team goals and objectives in compliance with study protocols, study specific plans, applicable federal and local regulatory requirements, ICH/GCP guidelines and Xeris SOPs
Oversee performance of CROs and clinical service providers to ensure compliance with study protocols and in accordance with scope of work, including setting expectations, training, oversight, managing timelines and deliverables, and issue management
Provide input to key study activities, including but not limited to site identification and selection, enrollment projections, clinical supply forecasting, organization of investigator and clinical service provider meetings, data reviews, and Clinical Study Reports
Track, collect, and review clinical documentation, such as risk logs, KPIs, monitoring metrics, recruitment performance, issues/actions, etc
Collaborate with internal and external stakeholders for the planning and execution of assigned clinical trials. Assist with development and management of project timelines and budgets
Review and track vendor invoices and ensure alignment with contracted scope of work
Write and/or contribute to the preparation of clinical protocols, amendments, informed consent forms, study plans, case report forms, and other essential study documents
Collaborate with legal and finance on the development and management of study specific agreements (i.e. non-disclosure agreements, clinical trial agreements, etc.)
Oversee clinical study site activities, review and approve monitoring visit reports and site communications, and visit sites as needed
Support TMF quality, reconciliation and inspection readiness throughout study lifecycle
Contribute to the development and revision of SOPs, processes, forms, templates, tools, etc. with the aim of continual improvement and efficiency
Support audits/inspections/inspection readiness activities, including preparation, response, and CAPA development
Perform other tasks or responsibilities as assigned
Qualification
Required
Bachelor's degree (BA/BS) or equivalent in life sciences or equivalent
6+ years executing clinical programs required
Experience overseeing CROs and external vendors required
Detailed knowledge of ICH/GCP Guidelines and current US FDA regulations
Experience with eClinical tools (e.g. eTMF, CTMS, EDC, etc)
Understanding of clinical study budgets and financial management practices
Self-motivated and able to work independently and effectively in a matrix/team environment
Ability to handle multiple projects, prioritize work and meet deliverables
Ability to proactively problem solve with a solutions-oriented mindset
Highly detail-oriented with strong quality and compliance focus
Strong computer skills, including a high level of proficiency in Microsoft Office Suite (Word, Excel, PowerPoint, Outlook, etc.)
Competencies: Organizational skills, Project Management, Time Management, Functional Leadership, Teamwork & Collaboration, Independent Judgement, Adaptability, Verbal and Written Communication skills
Preferred
Global clinical trial experience a plus
Experience in endocrinology preferred
Benefits
Bonus
Equity
Multiple paid time off benefits
Various health insurance options
Retirement benefits
Company
Xeris Pharmaceuticals, Inc.
We're a growth-oriented biopharmaceutical company improving patient lives by developing and commercializing advanced products across a range of therapies.
Funding
Current Stage
Public CompanyTotal Funding
$548.5MKey Investors
Hayfin Capital ManagementArmistice CapitalDeerfield
2024-03-06Post Ipo Debt· $200M
2022-01-03Post Ipo Equity· $30M
2021-03-11Post Ipo Equity· $27M
Leadership Team
Recent News
2026-01-09
The Motley Fool
2026-01-03
Company data provided by crunchbase